Veradigm™ Strengthens its Health Plan and Analytics Solutions by Finalizing Partnership with Pulse8
March 13 2019 - 7:01AM
Veradigm™, an Allscripts (NASDAQ: MDRX), business unit, announced
today that it has strengthened its strategic relationship with
Pulse8, a leader in healthcare analytics and technology company.
Pulse8 is the first, and only with a patent pending, healthcare
analytics and technology company delivering a complete enterprise
platform to provide visibility into the efficacy of Risk
Adjustment, Quality Improvement, and Pharmacy Management
programs. Pulse8 enables both health plans and at-risk
providers to achieve precise risk and quality scores in the
Medicare Advantage, Managed Medicaid, and ACA Commercial markets as
well as with Value-Based Payment models for Medicare.
Pulse8’s Illumin8™ Active Intelligence™ platform offers a suite of
uniquely pragmatic solutions that are powered by patent-pending
Dynamic Intervention Planning to deliver cost-effective and
appropriate interventions for closing gaps in documentation,
coding, and quality.
Pulse8 strengthens Veradigm’s existing health plan product suite
that delivers tools and services to help control costs while
optimizing health outcomes for health plan members. The newly
combined offering of clinical data exchange solutions, cutting-edge
analytics, and point-of-care engagement tools supports Veradigm’s
commitment to health plans and health care providers in their drive
towards quality outcomes while maximizing return on investment.
“The type of analytics, technology capabilities, and market
knowledge that Pulse8 brings to our team complements and
strengthens Veradigm’s existing health plan portfolio. John
Criswell, CEO, Pulse8, will be responsible for leading our combined
efforts,” said Tom Langan, CEO of Veradigm. “The move
reflects our strategy to extend and enhance existing solutions in
bold new ways to improve healthcare quality, risk score accuracy,
and healthcare cost reduction.”
“Pulse8 is dedicated to re-imagining data to help people live
healthy and independent lives through the innovation of
sophisticated analytics, predictive techniques, and data collection
tools that eliminate waste in healthcare,” John Criswell, CEO,
Pulse8. “We look forward to working together to achieve
success and return on investment for our health plan and provider
partners. Collectively, we now have the capability to expand
our mission to deploy solutions that improve financial performance
and generate significant ROI for payers and at-risk providers.”
Pulse8 will be hosting a Pre-Conference Workshop that pairs
Pulse8’s industry experts with some notable health plan partners on
Sunday, March 17th as a platinum sponsor at the 2019 RISE Nashville
Summit. The annual RISE Nashville Summit continues to be the
most meaningful conference for professionals of all levels in the
Medicare Advantage, Medicaid, and ACA Market.
About Veradigm Veradigm is an integrated data
systems and services business that combines data-driven clinical
insights with actionable tools for clinical workflow, research,
analytics, and media. Our solutions are designed to help key
healthcare stakeholders to improve the quality, efficiency, and
value of healthcare delivery - from biopharma to health plans,
healthcare providers, health technology partners, and most
importantly, the patients they serve. We are dedicated to
simplifying the complicated healthcare system with next-generation
healthcare solutions. That is how we are transforming health,
insightfully. To learn more, visit www.veradigmhealth.com, Twitter,
Facebook, and LinkedIn.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers and consumers to make better
decisions, delivering better care for healthier populations. To
learn more, visit www.allscripts.com,
Twitter, YouTube and It
Takes A Community: The Allscripts Blog.
© 2019 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
Allscripts, the Allscripts logo, and other
Allscripts marks are trademarks of Allscripts Healthcare, LLC
and/or its affiliates. All other products are trademarks of their
respective holders, all rights reserved. Reference to these
products is not intended to imply affiliation with or sponsorship
of Allscripts Healthcare, LLC and/or its affiliates.
For more information
contact:
Investors:
Stephen Shulstein 312-386-6735
Stephen.Shulstein@allscripts.com
Media:
Concetta Rasiarmos 312-447-2466
concetta.rasiarmos@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2024 to May 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From May 2023 to May 2024